Study of Leishmania infections
Part of Infections, Skin clinical trials.
This trial studies people with Leishmania infections (a parasitic disease often from sand fly bites). Researchers aim to better understand and treat the infection, and you may benefit from expert care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Must be between 3 and 100 years old.
- Must have a diagnosis of leishmaniasis, either confirmed by a biopsy or strongly suspected based on exposure and symptoms.
- Must be willing to let samples be stored for future research if needed.
- Must be able to provide informed consent (or have a parent/guardian do so).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the immune system reacts to Leishmania infection and searches for new ways to diagnose the disease. It may help develop better tests for leishmaniasis.
This study tests how your immune system responds to parts of a potential vaccine for leishmaniasis. Doctors will take small blood or skin samples to see if your body's cells react to these vaccine pieces, which could help design a better vaccine in the future.
This study checks whether workers in Montpellier's zoo, green spaces, or Ecolothèque have been exposed to germs from animals. It uses a blood test to look for past infections, which may help protect workers in similar jobs.
This study looks at how the body's immune system reacts to filarial infections—parasitic worms that affect millions worldwide. Researchers will observe your infection and response to treatment to better understand the disease and improve future care.
This study watches how leishmaniasis affects children over time. It helps doctors learn more about the disease in kids so they can improve care.
This study compares different drugs to find the best one for treating cutaneous leishmaniasis, a skin infection that causes sores. You might get one of several treatments, and the goal is to see which works best and is safest for patients like you.
Hear when a new Leishmaniasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.